# PORTAL: Patient-reported Outcomes After Routine Treatment of Atypical Lesions

> **NCT03070236** · NA · ACTIVE_NOT_RECRUITING · sponsor: **Dana-Farber Cancer Institute** · enrollment: 912 (actual)

## Conditions studied

- Breast Cancer

## Interventions

- **OTHER:** Survey

## Key facts

- **NCT ID:** NCT03070236
- **Lead sponsor:** Dana-Farber Cancer Institute
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2017-12-01
- **Primary completion:** 2019-05-27
- **Final completion:** 2030-02-25
- **Target enrollment:** 912 (ACTUAL)
- **Last updated:** 2026-02-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03070236

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03070236, "PORTAL: Patient-reported Outcomes After Routine Treatment of Atypical Lesions". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT03070236. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*